What is the primary treatment for vulvar lichen sclerosus?

Topical corticosteroids are considered the primary treatment for vulvar lichen sclerosus due to their anti-inflammatory properties, which help to reduce symptoms such as itching, discomfort, and inflammation associated with this condition. The use of potent topical corticosteroids can lead to significant improvement in the symptoms and can also help in preserving vulvar skin integrity by promoting healing and reducing the risk of scarring or further complications.

In cases of vulvar lichen sclerosus, the skin can become very thin and fragile, and persistent inflammation may lead to changes that can affect quality of life. Topical corticosteroids can effectively manage these symptoms by decreasing local inflammation and promoting healing. In contrast, other treatment options listed, such as antihistamines, oral antibiotics, and immunotherapy, do not address the underlying inflammatory process or symptoms of vulvar lichen sclerosus effectively. Antihistamines may provide some relief for itching but do not treat the underlying condition, while oral antibiotics are not indicated unless there is a secondary infection. Immunotherapy is not a standard approach for treating this condition as it targets a different mechanism compared to the pathology of lichen sclerosus.